IBN
Închide

Lista articolelor cu rezumate în limba engleza

Print PDF
Afisarea articolelor: 1-2(2)
2022
1.

Editorial: protecting hypoxia-inducible factor 1a and gut integrity with GB004-a promising therapeutic approach for ulcerative colitis? Authors' reply

. Alimentary Pharmacology and Therapeutics. 2022, nr. 6(55), 736-735. ISSN 0269-2813 ISSNe 1365-2036. (Cat. )
2.

Randomised clinical trial: a phase 1b study of GB004, an oral HIF-1α stabiliser, for treatment of ulcerative colitis

. Alimentary Pharmacology and Therapeutics. 2022, nr. 4(55), 411-401. ISSN 0269-2813 ISSNe 1365-2036. (Cat. )
 
 

1-2 of 2